Rational clinical use of near-patient analytical systems for molecular detection of infectious agents

Affiliations

Luppa Peter B.: Institute of Clinical Chemistry and Pathobiochemistry, University Hospital rechts der Isar der Technischen Universität München, Munich, Germany
Rabenau Holger F.: Institute of Medical Virology, Universitätsklinikum Frankfurt/Main, Frankfurt/Main, Germany
Gässler Norbert: Center for Laboratory Diagnostics, St. Bernward Hospital, Hildesheim, Germany
Huzly Daniela: Institute of Virology, Universitätsklinikum Freiburg, Freiburg, Germany
Nauck Matthias: Institute of Clinical Chemistry and Laboratory Medicine, Universitätsmedizin Greifswald, Greifswald, Germany
Reischl Udo: Institute of Clinical Microbiology and Hygiene, Universitätsklinikum Regensburg, Regensburg, Germany
Schoerner Christoph: Microbiology Institute – Clinical Microbiology, Immunology and Hygiene, Universitätsklinikum Erlangen, Erlangen, Germany
Zeichhardt Heinz: IQVD GmbH – Institut für Qualitätssicherung in der Virusdiagnostik, Berlin, Germany

Abstract

Tests for diagnosing infectious diseases (ID-POCT) play a special role among the available point-of-care testing (POCT) methods.